Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Pozycja w akcjach #41014
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Cena akcji
$0.00185055
Kapitalizacja rynkowa
$48.29K
Zmiana (1 dzień)
-3.55%
Zmiana (1 rok)
30.31%
Kraj
GB
Handel Nuformix plc (NFX)

Kategoria

Historia ceny akcji dla Nuformix plc (NFX)
Najwyższa cena zamknięcia: $0.00 dnia 2026-09-01

Najniższa cena zamknięcia: $0.04 dnia 2015-12-01
Historia cen akcji firmy Nuformix plc od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 0.00%
2025 410.64%
2024 -82.59%
2023 -11.19%
2022 -74.73%
2021 -56.41%
2020 -60.57%
2019 249.10%
2018 -26.41%
2017 -13.50%
2016 17.74%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$514.89 35.60%
US
$182.73 608.53%
US
$125.92 -4.58%
AU
$948.14 29.11%
NL
$730.39 7.23%
CH